Auxogyn licenses noninvasive embryo assessment technology from Stanford University

Oct 03, 2010

Auxogyn, Inc., a privately held medical technology company focused on women's reproductive health, today announced that it acquired an exclusive license from Stanford University to develop a set of products that may allow medical practitioners in the field of assisted reproduction to significantly improve the effectiveness of in vitro fertilization (IVF) procedures.

The technology licensed from Stanford is described in a publication titled 'Non-invasive imaging of before embryonic genome activation predicts development to the blastocyst stage,' now appearing in the online edition of .

This landmark study demonstrated, for the first time, that human embryo fate is already determined at the four-cell stage of development. The article is authored by Professor Renee Reijo Pera, Dr. Connie Wong, Dr. Kevin Loewke, Dr. Nancy Bossert, Dr. Barry Behr, Dr. Christopher De Jonge and Dr. Thomas Baer and showed that measuring a unique set of non‑invasive imaging parameters by day 2 may allow an embryologist to predict the embryos that will reach the blastocyst (day 5) stage of development with a very high degree of accuracy.

"Blastocyst formation is a critical time point in human embryo development and provides more objective criteria for selecting which embryo(s) to transfer," said Lissa Goldenstein, president and chief executive officer of Auxogyn, Inc. "For years, researchers have searched for ways to predict the embryos most likely to reach the blastocyst stage in order to enable earlier transfer and ultimately improve live birth rates for in vitro fertilization procedures."

"Building on the technology licensed from Stanford, we are developing a product that assesses early embryo viability at the 4-cell stage. We believe that generating key clinical data assessments may enable embryologists to improve the effectiveness of (IVF) procedures while providing women experiencing infertility the highest quality of patient care," continued Ms. Goldenstein.

Explore further: Synbreed project bridges the gap between animal and plant breeding

Provided by AB Corporate Communications

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Stem cell lines created from discarded IVF embryos

Feb 05, 2008

Human embryos that are discarded every day as medical waste from in vitro fertilization (IVF) clinics could be an important source of stem cells for research, according to a team of Harvard Stem Cell Institute researchers ...

First use of DNA fingerprinting to identify viable embryos

May 14, 2008

Fertility researchers have used DNA fingerprinting for the first time to identify which embryos have implanted after in vitro fertilisation (IVF) and developed successfully to result in the births of healthy babies. The technique, ...

Recommended for you

Protecting crops from radiation-contaminated soil

6 hours ago

Almost four years after the accident at the Fukushima Daiichi Nuclear Power Plant in Japan, farmland remains contaminated with higher-than-natural levels of radiocesium in some regions of Japan, with cesium-134 ...

Activating genes on demand

19 hours ago

When it comes to gene expression - the process by which our DNA provides the recipe used to direct the synthesis of proteins and other molecules that we need for development and survival - scientists have ...

Metabolic path to improved biofuel production

20 hours ago

Researchers with the Energy Biosciences Institute (EBI), a partnership that includes the Lawrence Berkeley National Laboratory (Berkeley Lab) and the University of California (UC) Berkeley, have found a way ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.